In our study, for the first time, we show that Sema3d, one of the semaphorins, is capable of suppressing HCC proliferation, invasion, and metastasis through Pi3k/AKT signaling and also has the potential to be an effective biomarker to predict the prognosis of HCC. The gene discussed is AKT1; the disease is hepatocellular carcinoma.